Clinical Trials Day Breakfast
Health Sciences Learning Center (HSLC) 750 Highland Avenue, Madison, United StatesJoin us, in-person, for an informal, drop-in breakfast in the Health Sciences Learning Center (HSLC) Atrium!
Join us, in-person, for an informal, drop-in breakfast in the Health Sciences Learning Center (HSLC) Atrium!
Learn what bias is, see examples of how it shows up in healthcare, the language we use, and clinical trials. Also, learn a few strategies to move towards a more race-conscious approach that will address our unconscious biases.
As part of the UW Clinical Trials Institute's Clinical Trials Day celebration, this keynote event will focus on UW's participation in the breast cancer vaccine clinical trial with perspectives from the researcher and a participant.
Join us, in-person, in the Health Sciences Learning Center (Room 1309) to view a livestream of a Research Subject Panel, presented by the Wisconsin chapter of the Association of Clinical Research Professionals (ACRP).
Hear from various experts (in-person or via Zoom) across UW–Madison, Microsoft, and peer institutions on the value of cloud research and the benefits of Azure.
Learn about projects using community engagement and collaboration with historically underrepresented populations in primary care research.
Join the race to benefit cancer research at the UW Carbone Cancer Center!
The UW Clinical Trials Institute is pleased to welcome the OutReach LGBTQ+ Community Center for a 'LGBTQ+ 101' session to explore intersectionality and its importance as a framework to understanding and supporting the LGBTQ+ community and identity.
Our vision for West Campus aims to enrich the campus experience for all who visit, work, study, and play in that area, by creating opportunities for new career pathways, expanding livelihoods, and providing space for important discovery.
Engage with leaders within the UW clinical research community at this open Q+A ‘Research Forum’. This is an opportunity to ask questions about clinical research-related topics such as the IRB, informatics, and clinical trials.
As part of the FDA’s efforts to be responsive to the rapidly evolving clinical trial landscape and clarify the Agency’s recommendations on the conduct of DCTs, the FDA will provide an overview of the draft guidance titled Decentralized Clinical Trials for Drugs, Biological Products, and Devices.
Panelists will share their experiences participating in clinical research, accessibility challenges they have faced, and suggestions for systemic improvements.